Pfizer shelves haemophilia gene therapy Beqvez amid low demand
Pfizer said resources will be directed to its other haemophilia gene therapy Hympavzi.
Pfizer said resources will be directed to its other haemophilia gene therapy Hympavzi.
What's Your Reaction?
